Search for: "Janssen Pharmaceuticals Inc." Results 1 - 20 of 244
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jan 2016, 7:49 am by Law Offices of Jeffrey S. Glassman
Ortho-McNeil-Janssen Pharma., Inc: Defective Drug Lawsuits appeared first on Product Liability Lawyer Blog. [read post]
4 Mar 2016, 8:00 am by Robert Kreisman
The federal district court has entered a ruling that Janssen Pharmaceuticals Inc. should pay penalties for violating South Carolina law. [read post]
2 Sep 2012, 3:20 pm
Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, agreed Thursday to pay $181 Million to settle cases brought by 36 states and the District of Columbia alleging illegal marketing of its anti-psychotic drugs for off-label, non-approved uses. [read post]
2 Sep 2012, 3:20 pm
Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, agreed Thursday to pay $181 Million to settle cases brought by 36 states and the District of Columbia alleging illegal marketing of its anti-psychotic drugs for off-label, non-approved uses. [read post]
7 Sep 2012, 9:41 am
Last week Janssen Pharmaceuticals Inc. and parent company Johnson & Johnson on Thursday announced a $181 million settlement with 36 states and the District of Columbia over charges of marketing anti-psychotic drugs for non-approved uses. [read post]
15 Nov 2018, 9:28 am by Jordan Ross
New Jersey’s Attorney General filed a lawsuit Tuesday against Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson, for misleading patients and prescribers about the addictive risks associated with the use of its drugs. [read post]
1 Nov 2015, 9:57 pm by Patent Docs
Par Pharmaceutical Inc. et al. 1:15-cv-00679; filed August 3, 2015 in the District Court of Delaware • Plaintiffs: Janssen Biotech Inc.; Janssen Oncology Inc.; Janssen Research & Development LLC • Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
29 Dec 2013, 9:15 pm by Patent Docs
Janssen Pharmaceuticals Inc. et al. v. [read post]
18 May 2014, 8:42 pm by Patent Docs
Mylan Pharmaceuticals Inc. et al. 1:14-cv-00594; filed May 12, 2014 in the District Court of Delaware • Plaintiffs: Alza Corp.; Janssen Pharmaceuticals Inc. [read post]
14 Jun 2015, 8:59 pm by Patent Docs
Janssen Pharmaceuticals Inc. v. [read post]
14 Nov 2013, 5:00 am
Janssen Pharmaceuticals, Inc., a New Jersey pharmaceutical company of J&J, provides medicines for attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health. [read post]
20 Jun 2011, 7:47 am by info@thomasjhenrylaw.com
Ortho-McNeil-Janssen Pharmaceuticals, Inc., a member of the Johnson and Johnson family, has issued a recall of about 40,000 bottles of Risperdal and its generic form. [read post]
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
23 May 2011, 9:59 pm by Patent Docs
Impax Laboratories, Inc. et al. 1:11-cv-00395; filed May 5, 2011 in the District Court of Delaware • Plaintiffs: Alza Corp.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
23 May 2012, 9:22 pm by Patent Docs
Searle, LLC • Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]